Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Stress-induced NKG2D ligands are surface proteins belonging to the MICA/B and ULBP families whose expression is upregulated in response to cellular stress, such as DNA damage, oxidative stress, or oncogenic signals. These ligands are recognized by the NKG2D receptor expressed on natural killer cells, cytotoxic T cells, and certain other immune populations, triggering immune-mediated lysis of stressed or transformed cells[1][2][3][4][6]. Cancer cells frequently modulate the expression, maturation, and shedding of these ligands to evade immune detection, making NKG2D ligand pathways central to both immune surveillance and tumor immune escape. Therapeutic interventions are being developed to exploit ligand expression for targeted immunotherapy and to prevent tumor-mediated suppression of the immune response[1][2][3][6].
Induction/upregulation of stress ligands to promote immune-mediated elimination of tumor cells Blocking NKG2D-ligand interaction to prevent immune evasion and enhance cytotoxicity Shedding inhibition to increase surface ligand expression and sensitivity to immune effectors
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stress-induced NKG2D ligands (MICA, MICB, ULBP1-6) (NKG2D ligands (NKG2DL)).